SHOULDER & ELBOW
Outcomes not improved with platelet-rich fibrin matrix in arthroscopic rotator cuff repair
This report has been verified
by one or more authors of the
original publication.
Am J Sports Med. 2013 Feb;41(2):263-70. doi: 10.1177/0363546512467621. Epub 2012 Nov 30
60 patients were randomized to determine the efficacy of platelet-rich fibrin matrix (PRFM) in arthroscopic rotator cuff repair. Patients were allocated to receive repair either with or without added PRFM. Pain and narcotic use were monitored in the recovery room following surgery, structural outcome was MRI-assessed 3-5 months postoperatively, and final follow-up of functional outcomes was performed at least one year postoperatively. Results indicated there were no significant improvements in any outcome measurement with the use of PRFM, and UCLA scores were observed to be significantly reduced in the PRFM group.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
